<DOC>
	<DOC>NCT02960958</DOC>
	<brief_summary>The aim of this study is to investigate discriminant metabolites in urine from patients with rheumatoid arthritis (RA) from healthy individuals. Then we determine if the patient's metabolic fingerprint could predict the development or flare-up of RA.</brief_summary>
	<brief_title>Metabolome Analysis in Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description>Compare metabolites between RA patients and healthy individuals. 1. Collection urine sample 2. Assessing urine metabolites by 1H NMR spectroscopy 3. Analyzing the relationships between metabolites and clinical variables</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<criteria>All patients with rheumatoid arthritis meet 2010 American College of Rheumatology/European League against Rheumatism classification criteria. Comorbid with other autoimmune diseases Confirmed with amyloidosis Chronic kidney disease (estimated GFR &lt; 60 ml/min/1.73m2) Chronic liver disease Thyroid disease Pregnancy Solid tumor/hematologic malignancy within 5 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Rheumatoid arthritis</keyword>
	<keyword>Metabolomics</keyword>
	<keyword>urine</keyword>
</DOC>